Surgery Partners Inc
General ticker "SGRY" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $2.8B
Surgery Partners Inc does not follow the US Stock Market performance with the rate: -3.4%.
Estimated limits based on current volatility of 3.1%: low 20.03$, high 21.33$
Factors to consider:
- Current price 44.6% below estimated low
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [30.74$, 54.18$]
- 2023-12-31 to 2024-12-30 estimated range: [38.07$, 64.41$]
Financial Metrics affecting the SGRY estimates:
- Positive: 0.10 < Non-GAAP EPS, $ of 0.13
- Negative: Operating cash flow per share per price, % of 6.43 <= 7.18
- Positive: 9.05 < Operating profit margin, % of 13.59
- Negative: Interest expense per share, $ of 2.55 > 0.74
- Negative: Industry operating cash flow per share per price (median), % of 1.95 <= 3.85
Short-term SGRY quotes
Long-term SGRY plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $1,860.10MM | $2,225.10MM | $2,539.30MM |
| Operating Expenses | $1,613.50MM | $1,922.90MM | $2,194.10MM |
| Operating Income | $246.60MM | $302.20MM | $345.20MM |
| Non-Operating Income | $-265.40MM | $-221.00MM | $-234.90MM |
| Interest Expense | $201.80MM | $221.00MM | $234.90MM |
| Income(Loss) | $-18.80MM | $81.20MM | $110.30MM |
| Taxes | $-20.10MM | $10.50MM | $23.30MM |
| Profit(Loss) | $1.30MM | $70.70MM | $87.00MM |
| Stockholders Equity | $115.60MM | $1,089.00MM | $1,998.20MM |
| Inventory | $56.40MM | $61.10MM | $71.40MM |
| Assets | $5,413.20MM | $6,117.60MM | $6,682.10MM |
| Operating Cash Flow | $246.90MM | $87.10MM | $158.80MM |
| Capital expenditure | $42.90MM | $57.60MM | $80.60MM |
| Investing Cash Flow | $-88.40MM | $-331.70MM | $-307.90MM |
| Financing Cash Flow | $66.70MM | $316.30MM | $42.10MM |
| Earnings Per Share* | $0.03 | $0.98 | $0.95 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.